Strong NKCC1 immune reactivity is characteristic of the aberrant neuronal component of the glioblastoma, while the increase in neuronal NKCC1 expression is not characteristic of the peri-lesional zone of tumor samples. This evidence concerns the gene SLC12A2 and glioblastoma.